Kadmon Pharma takes over Three Rivers Pharma
With this acquisition, Three Rivers is expected to serve as the commercial and operational cornerstone for Kadmon. Three Rivers is known to currently market several products for the
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.